Brief: Liminatus Pharma To Launch 'American BNB Strategy' Subsidiary And Target Up To $500 Mln Fund For BNB Investment As Part Of Crypto Market Initiative
28/07/2025 12:32
July 28 (Reuters) - Liminatus Pharma Inc LIMN.O: LIMINATUS PHARMA INC. TO LAUNCH “AMERICAN BNB STRATEGY” SUBSIDIARY AND TARGET UP TO $500 MILLION FUND FOR BNB INVESTMENT AS PART OF CRYPTO MARKET INITIATIVE Source text: ID:nGNXbvbfCy Further company coverage: LIMN.O (Reporting by Anshi Sancheti) ((Anshi.Sancheti@thomsonreuters.com;))
Recent news on Liminatus Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Liminatus Pharma Announces Reverse Stock Split Of Its Common Stock
Brief: Liminatus Pharma Announces Planned Phase 1 Clinical Trial Of Iba101, A Next-Generation Cd47 Blocking Antibody
Brief: Liminatus Pharma Enters Settlement Agreement With Clear Street LLC